{"@odata.context":"https://open.ejn.gov.ba/$metadata#Awards","value":[{"Id":1444850,"LotName":null,"Value":235943.82,"ContractDate":"2016-10-20T22:00:00Z","ContractingAuthorityId":47196,"ContractingAuthorityName":"ZAVOD ZDRAVSTVENOG OSIGURANJA I REOSIGURANJA FEDERACIJE BOSNE I HERCEGOVINE","ContractingAuthorityTaxNumber":"4200642000008","ContractingAuthorityCityName":"NOVO SARAJEVO","ContractingAuthorityType":"PublicEntity","ContractingAuthorityActivityTypeName":"Zdravstvo","ContractingAuthorityAdministrativeUnitType":"Entity","ContractingAuthorityAdministrativeUnitName":"Federacija Bosne i Hercegovine","ProcedureId":1228383,"ProcedureName":"lijek REVLIMID (INN lenalidomid) kapsule 5 mg, 10 mg, 15 mg i 25 mg","ProcedureNumber":"804-4-1-48/16","ProcedureType":"NegotiatedProcedureWithoutProcurementNotice","ContractType":"Goods","ContractCategoryName":"Kupovina","ContractSubcategoryName":null,"HasLots":false,"IsAuctionOnline":false,"IsMasterAgreement":false,"IsDefenseAndSecurity":false,"IsJointProcurement":false,"IsOnBehalfProcurement":false,"AwardCriterion":"LowestPrice","NoticeId":12449,"NoticeNumber":"804-4-1-48-5-50/16","AdditionalInformation":null,"AllowedSubcontracting":false,"AnnualValue":null,"CompletedWithNegotiation":false,"EuFundsUsed":false,"HighestAcceptableOfferValue":235943.82,"IsContractConcluded":false,"LegalRemediesUsed":false,"LowestAcceptableOfferValue":235943.82,"MonthlyValue":null,"NumberOfAcceptableOffers":1,"NumberOfReceivedOffers":1,"PreferentialTreatmentUsed":false,"PriorAnnouncementNumber":null,"PriorAnnouncementId":null,"ReasonsForNegotiatedProcedure":"Zbog suštinskih i dokazivih razloga koji se odnose na zaštitu eskluzivnih prava.","RegulationQuoteId":75,"RegulationQuoteName":"Član 21. Stav (1) Tačka c)","SubcontractingShare":null,"SubcontractingShortDescription":null,"SubcontractingValue":null,"MasterAgreementEndDate":null,"MasterAgreementStartDate":null,"LastUpdated":"2023-12-21T21:44:24.3670883Z"}]}